Arachis hypogaea (Valencia Peanut)

Valencia peanuts (Arachis hypogaea) contain high concentrations of unsaturated fatty acids, particularly 36-58% linoleic acid and 11-42% oleic acid, along with 17-22% plant-based protein. These bioactive lipids support cardiovascular health through membrane stabilization and inflammatory pathway modulation.

Category: Legume Evidence: 2/10 Tier: Preliminary (in-vitro/animal)
Arachis hypogaea (Valencia Peanut) — Hermetica Encyclopedia

Origin & History

Arachis hypogaea (Valencia Peanut) is a specific cultivar of the common peanut, a legume native to South America. It is an oil-rich seed, characterized by a high content of fats (38-48%) and proteins (17-22%), harvested from pods that grow underground. Production involves general processing, with no unique extraction methods specified beyond those used for peanut products like oils or skin extracts.[1][2][5]

Historical & Cultural Context

The provided research dossier documents no specific historical or traditional medicinal uses for the Valencia Peanut cultivar. The available literature emphasizes modern nutritional and chemical profiling over any ethnomedicinal context.[1][2][5]

Health Benefits

["\u2022 Provides a rich source of unsaturated fatty acids, including 36-58% linoleic acid and 11-42% oleic acid, based on compositional analysis.[2][3]", "\u2022 Contains a significant amount of plant-based protein, with seed composition ranging from 17-22%, based on chemical profiling.[2][3]", "\u2022 The tegument (skin) is a concentrated source of phenolic compounds (74 mg GAE/g) and caffeic acid (2.46%) according to in vitro analysis of ethanolic extracts.[1]", "\u2022 Supplies tocopherols (Vitamin E), primarily gamma-tocopherol, at concentrations of 390-706 ppm, as identified in chemical studies.[2]", "\u2022 Considered safe for nutritional consumption, as ethanolic extracts showed no cytotoxicity or genotoxicity in preliminary in vitro safety screenings.[1]"]

How It Works

Valencia peanuts' high linoleic acid content (36-58%) modulates prostaglandin synthesis through cyclooxygenase pathways, while oleic acid (11-42%) influences membrane fluidity and reduces inflammatory cytokine production. The abundant plant proteins provide essential amino acids that support nitric oxide synthesis via the L-arginine-nitric oxide pathway, promoting vascular health.

Scientific Research

The provided research dossier contains no human clinical trials, randomized controlled trials (RCTs), or meta-analyses for the biomedical application of Arachis hypogaea (Valencia Peanut). Existing data is limited to in vitro safety assessments and chemical composition analysis, with no PubMed PMIDs for human efficacy studies available in the results.[1][2][6]

Clinical Summary

Current evidence for Valencia peanuts is primarily based on compositional analyses rather than dedicated clinical trials. Observational studies on peanut consumption generally show associations with improved cardiovascular markers, but specific research on Valencia variety effects is limited. The documented fatty acid profile suggests potential benefits, though controlled human trials are needed to establish therapeutic efficacy and optimal dosing protocols.

Nutritional Profile

Macronutrients (per 100 g raw kernel): Total fat 44–56%, comprising oleic acid (11–42%), linoleic acid (36–58%), palmitic acid (8–14%), and stearic acid (1–4%); protein 17–22% (rich in arginine ~3.1 g/100 g, glutamic acid, and aspartic acid; limiting amino acids are methionine, lysine, and threonine); total carbohydrates 16–26% with dietary fiber ~8.5 g (predominantly insoluble); sucrose ~4–5%, stachyose and raffinose present in small amounts. Micronutrients: niacin (vitamin B3) ~12–17 mg/100 g (one of the richest plant sources); folate (vitamin B9) ~240 µg/100 g; thiamine (B1) ~0.6 mg; vitamin E as α-tocopherol ~8–10 mg/100 g and γ-tocopherol ~5–7 mg/100 g; pantothenic acid (B5) ~1.8 mg. Minerals: magnesium ~168–180 mg/100 g, phosphorus ~376–400 mg/100 g, potassium ~705 mg/100 g, zinc ~3.3 mg, iron ~4.6 mg (non-heme, bioavailability ~5–12%, enhanced by concurrent vitamin C intake), copper ~1.1 mg, manganese ~1.9 mg, calcium ~92 mg (bioavailability reduced by phytic acid). Bioactive compounds: resveratrol (trans-resveratrol) ~0.02–1.8 µg/g in raw kernels (increases significantly with sprouting/germination up to ~12 µg/g); p-coumaric acid ~4–8 mg/100 g in skins; phenolic content in tegument (skin) ~74 mg GAE/g; caffeic acid present in skins as a major hydroxycinnamic acid; proanthocyanidins (A-type) concentrated in skins ~17 mg/g; phytosterols including β-sitosterol ~61–85 mg/100 g, campesterol ~11–15 mg/100 g, and stigmasterol ~5–8 mg/100 g; coenzyme Q10 (ubiquinone) ~2.7 mg/100 g. Anti-nutritional factors: phytic acid ~1.0–1.8% (chelates minerals, reducing bioavailability of iron, zinc, and calcium; can be partially reduced by soaking, roasting, or fermentation); trypsin inhibitors present at low levels (~5–10 TIU/mg) compared to soybean. Valencia-type peanuts tend toward higher sugar content (~5–6% sucrose) and are frequently consumed boiled, which increases bioavailability of certain phenolics (p-coumaric acid, resveratrol) through cell wall disruption while reducing phytic acid content by ~20–30%. Roasting increases Maillard reaction products and may reduce some heat-labile B-vitamins (thiamine loss ~10–15%) but enhances overall phenolic extractability and sensory-driven consumption.

Preparation & Dosage

No clinically studied dosage ranges are reported for extracts, powders, or standardized forms of Arachis hypogaea (Valencia Peanut). Nutritional consumption is considered safe based on in vitro data, but no therapeutic doses have been established. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

No synergistic ingredients are identified in the provided research dossier.

Safety & Interactions

Valencia peanuts are generally safe for most individuals but pose severe allergy risks for those with peanut hypersensitivity, potentially causing anaphylaxis. High caloric density may contribute to weight gain if consumed excessively. The omega-6 fatty acid content may theoretically interact with anticoagulant medications by affecting prostaglandin synthesis. Pregnant and breastfeeding women should consume in moderation due to potential allergenic protein transfer.